You are here: Policies > Familial Hypercholesterolaemia (adult)

Familial Hypercholesterolaemia (adult)

The UK NSC policy on Familial Hypercholesterolaemia screening in adults


Type Adult
Last review completed December 2011
Next review due in 2014/15
Policy recommendation     Systematic population screening programme not recommended

A national screening programme for FH is not recommended.

Key downloads Last external review - Expert Review for Familial Hypercholesterolaemia

What is screening?

Screening is a process of identifying apparently healthy people who may be at increased risk of a disease or condition. They can then be offered information, further tests and appropriate treatment to reduce their risk and/or any complications arising from the disease or condition. It is important to ensure that the benefits and downsides of screening have been properly thought through. The UK National Screening Committee (UK NSC) is responsible for reviewing screening policies every 3 years and making recommendations to ministers in the 4 UK countries about whether to not a screening programme for a certain condition should be set up.

» Find out more about screening, the role of the UK NSC or the policy review process

More about Familial Hypercholesterolaemia (adult)

Familial hypercholesterolaemia (or hyperlipidaemias) are inherited metabolic disorders which include harmful disorders resulting in an excess of cholesterol and/or triglyceride in the blood. Cholesterol is transported round the body in combination with proteins, known as lipoproteins, low density lipoproteins (LDL) and beneficial high density lipoproteins (HDL). Triglyceride travels within very low density lipoproteins (VLDL) and chylomicrons.

» Read more about familial hypercholesterolaemia on NHS Choices

Policy stakeholders

British Heart Foundation
British Inherited Metabolic Disease Group
Genetic Alliance UK
Royal College of Pathologists
Royal College of Physicians
Royal College of Physicians and Surgeons of Glasgow
Royal College of Physicians of Edinburgh
Scottish Lipid Forum

The stakeholder groups will be involved when the policy is next reviewed. If you think your organisation should be added, please contact us. More about the policy review process, including the role of stakeholders, can be found in the guide to Engaging with the UK NSC's policy review process.

Related documents

icon Summary of Policy and Consultation Responses for Familial Hypercholesterolaemia (PDF document, 598KB, 15/12/11)

More options

Go to top
page image